Last reviewed · How we verify
NCT05506722
Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity
NA trial testing Testes shocker in Infertility, Male in 250 participants. Status unknown.
1 January 2023
Quick facts
| Lead sponsor | University of Baghdad |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 250 |
| Start date | 1 September 2022 |
| Primary completion | 1 January 2023 |
| Estimated completion | 1 January 2023 |
| Sites | 1 location across Iraq |
Drugs / interventions tested
- Testes shocker
Conditions studied
- Infertility, Male — all drugs for Infertility, Male →
- Infertility Unexplained — all drugs for Infertility Unexplained →
- Infertility Due to Complete Spermatogenic Arrest — all drugs for Infertility Due to Complete Spermatogenic Arrest →
- Oligospermia — all drugs for Oligospermia →
Sponsor
University of Baghdad
Who can join
Adults 18 to 60, male only, with Infertility, Male or Infertility Unexplained. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Infertility was reported in approximately 15% of all heterozygous couples, with male factor accounting for nearly half the cases. This typically occurs due to low sperm production, sperm dysfunction, and sperm delivery obstruction. Etiology of male infertility can be attributed to many factors including acute or chronic illness, accidents, and lifestyle choices.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05506722
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility, Male
Currently open trials in the same condition.
- NCT06950203 — The Effect of Supplementation With Fish Oil (EPAX EVOLVE 05) on Sperm Quality · NA · recruiting
- NCT06539585 — Scanning the Meiotic Spindle in Assisted Reproductive Techniques to Assess Oocyte Quality · NA · active not recruiting
- NCT05514223 — Measuring Free Radicals in Human Sperm Cells Related to Microbiota and Lifestyle Factors · recruiting
- NCT06841861 — Spermatogonial Differentiation Via Testicular Organoid · Phase 1, PHASE2 · recruiting
- NCT05903859 — Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI) · Phase 3 · recruiting
Other University of Baghdad trials
Trials by the same sponsor.
- NCT07417839 — (Effect of Toy Nebulizer Versus Distraction Cards on Children's Fear and Parental Satisfaction During Nebulization Thera · NA · not yet recruiting
- NCT07456657 — Effect of Lavender Aromatherapy Massage on Pain and Wrist Mobility in Rheumatoid Arthritis · NA · not yet recruiting
- NCT07460089 — Premature Infant Oral Motor Intervention vs. Pacifier for Oral Feeding Transition in Preterm Infants · NA · not yet recruiting
- NCT07350343 — The Predictability of Directly Printed Versus Thermoformed Clear Aligners · NA · enrolling by invitation
- NCT07362160 — Clear Orthodontic Expander Versus Hyrax · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05506722 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Baghdad
- Last refreshed: 3 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05506722.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing